Eric Shiozaki, PhD
InvestorPartner at Revelation Partners · Partner at DCVC (Data Collective) · Board director at Auron Therapeutics
San Francisco, California, United States
Writes $5M – $50M checks
Find your path to Eric
704 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.
Wes NicholsunlockedEric: together at The Johns Hopkins University
×2Eric: together at University of California, Los Angeles
×8Eric: together at The Johns Hopkins University
Eric: together at DCVC (Data Collective)
About
Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Board director at Auron Therapeutics
Intro paths
→
In turn, Eric can intro founders to Auron Therapeutics's investors below.
Auron Therapeutics's investors · 2
Co-founders at Auron Therapeutics
KY
Katharine YenExecutive Officer, Director
KY
Kate YenFounder
Experience
- Revelation PartnersPartnercurrent2025 — presentSan Francisco Bay Area
- Revelation PartnersVenture Partner2024 — 2025San Francisco Bay Area
- DCVC BioPartner2021 — 2024San Francisco Bay Area
- Novo HoldingsPartner - Novo Ventures2018 — 2021San Francisco Bay Area
- Novo HoldingsPrincipal - Novo Ventures2014 — 2017San Francisco Bay Area
- Apposite CapitalDirector2011 — 2014San Francisco Bay Area
- Apposite CapitalAssociate Director2009 — 2011San Francisco Bay Area
- VitaPath GeneticsDirector of Corporate Development & Strategy2009San Francisco Bay Area
- Burrill & CompanyAssociate2007 — 2008San Francisco Bay Area
- Burrill & CompanyIntern2007San Francisco Bay Area
- University of California, Los AngelesTechnology Transfer Associate2006 — 2007Los Angeles
- University of California, Los AngelesLeukemia & Lymphoma Society Postdoctoral Fellow2004 — 2007Los Angeles
- Princeton UniversityPostdoctoral Researcher2003 — 2004Princeton, New Jersey, United States
Skills & more
Biotechnology8Venture Capital27Technology Transfer9Medical Devices6Investments8Start-ups20Management2Entrepreneurship10Due Diligence10Corporate Development9Portfolio Management2Corporate Finance2
+8 more
StrategyMergers & AcquisitionsFinancePrivate EquityProtein ChemistryLifesciencesGeneticsPharmaceutical IndustryFrom Eric's professional profile.
Colleagues at Revelation Partners
Chris Bayliss
Vice President at Revelation Partners
Colleen Hochberger
Manager, Marketing & Operations at Revelation Partners
Doug Fisher
Partner, MD at Revelation Partners
Doug Fisher, MD
Partner at Revelation Partners
Fred Lee
Partner at Revelation Partners
Garrett Brown
Senior Associate at Revelation Partners
Jonathan Au
Partner at Revelation Partners
Jordan Bloom
Associate at Revelation Partners
Network9
Alan CohenScout
General Partner at DCVC (Data Collective)
Ali TamasebScout
General Partner at DCVC (Data Collective)
Chris BoshuizenScout
Partner at DCVC (Data Collective)
James HardimanScout
General Partner at DCVC (Data Collective)
Jason PontinScout
General Partner at DCVC (Data Collective)
Anna Fokina
Investment Director DCVC Bio at DCVC (Data Collective)
Daniel Coley
Associate at Cofounders Capital
Irfan Ahmad
Investor at DCVC (Data Collective)
Joe Oleynik
Investor at DCVC (Data Collective)
Investors connected to Eric in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Eric Shiozaki, PhD?
- Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.
- Where does Eric Shiozaki, PhD work?
- Eric Shiozaki, PhD is Partner at Revelation Partners and Board director at Auron Therapeutics.
- What does Eric Shiozaki, PhD invest in?
- Eric Shiozaki, PhD invests in Biotech, Healthtech, Medical Devices.
- What check size does Eric Shiozaki, PhD write?
- Eric Shiozaki, PhD typically writes checks of $5M – $50M.
- Where did Eric Shiozaki, PhD go to school?
- Eric Shiozaki, PhD studied at Princeton University (Ph.D., Molecular Biology); The Johns Hopkins University (BA, Biophysics).
Same school
Also attended Princeton University879
Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures
.jpg)
+ 873 more
Also attended The Johns Hopkins University442
Dave JohnsonCo-founder & CEO of Dash BioNicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla Ventures
+ 436 more
Shared employers
Also worked at Revelation Partners14
Prashant GangwalChief Financial Officer at Altos Ventures at 1809 CapitalMike BoggsManaging Partner at Revelation PartnersJonathan AuPartner at Revelation PartnersDoug Fisher, MDPartner at Revelation PartnersFred LeePartner at Revelation PartnersLiz StaleyPartner & Chief Compliance Officer at Revelation Partners
+ 8 more
Also worked at DCVC Bio6
John HamerManaging Partner, DCVC Bio at DCVC (Data Collective)Kiersten SteadManaging Partner, DCVC Bio at DCVC (Data Collective)Richard WainesAssociate, DCVC Bio at DCVC (Data Collective)Christopher MeldrumEntrepreneur In Residence, DCVC Bio at DCVC BioAimee VillamayorOffice Manager & Executive Assistant, DCVC Bio at DCVC BioLuca ParolariSenior Associate at DCVC (Data Collective)
Also worked at Novo Holdings44
Jeffrey LowPartner at Averin CapitalRodrigo SantosEntrepreneur in Residence at Cambridge Innovation CapitalStephan ChristgauFounding Partner at EIR VenturesHelle BachChief People Officer at Novo HoldingsKasim KutayCEO at Novo HoldingsKasper Sobfeldt JahnChief Strategy Officer at Novo Holdings
+ 38 more
